CS
RGEN icon

Candriam SCA’s Repligen RGEN Stock Holding History

Candriam SCA’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– – – 584
2023
Q2 		– Sell
-5,668
Closed -$878K – 844
2023
Q1 		$878K Buy
5,668
+2,113
+59% +$377K 0.01% 714
2022
Q4 		$602K Buy
+3,555
New +$645K ﹤0.01% 787
2021
Q4 		– Sell
-14,064
Closed -$4.06M – 852
2021
Q3 		$4.06M Sell
14,064
-16,406
-54% -$4.21M 0.03% 436
2021
Q2 		$6.08M Buy
+30,470
New +$5.91M 0.04% 369

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Candriam SCA's RGEN Position: Q1 2024 in Review

Candriam SCA held its Repligen (RGEN) position steady in Q1 2024 at 0 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #584.

Candriam SCA first reported a position in RGEN in Q2 2021 and has held it in 4 quarters since. The position peaked at $6.08M in Q2 2021. 487 funds tracked by Wall St. Rank hold RGEN as of Q1 2024.

  • Candriam SCA held 0 shares of Repligen worth $1.14M as of Q1 2024.
  • Candriam SCA left its Repligen share count unchanged in Q1 2024.
  • Repligen made up 0.01% of Candriam SCA's portfolio in Q1 2024, its #584 holding.
  • Candriam SCA first reported a position in Repligen in Q2 2021 and has held it in 4 quarters since.
  • Candriam SCA's Repligen position peaked at $6.08M in Q2 2021.
  • 487 funds tracked by Wall St. Rank held Repligen as of Q1 2024.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.